Product Name: Human IFNA1 Antibody (Rontalizumab, Research Use)
Catalog Number: NBR-0206
Target Name: IFNA1
Trade Name: Rontalizumab
Antibody Drug Description: Rontalizumab is a humanized monoclonal antibody[1] being developed by Genentech. As of November 2009, it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IFNA1
Synonyms: IFL; IFN; IFN-ALPHA; IFN-alphaD; IFNA; IFNA13
Target Description: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.
Ensembl: ENSG00000197919 
Uniprot: P01562